• Home
  • Contact

Tag: Merck

News

Amphista Lands Megadeals to Smash Cancer using Protein Degradation

3 weeks ago 16 Likes 47
News

You Need to Reach Market Readiness? What Now?

1 year ago 11 Likes 159
News

Afraid of Tech Transfer? There’s No Need!

1 year ago 12 Likes 219
News

Investors Up the Ante for Drugs Striking Cancer via DNA Repair

1 year ago 7 Likes 168
News

Bioburden Detection: The Hidden Bottleneck in Drug Manufacturing

2 years ago 8 Likes 214
News

The Roller Coaster of Gene Therapy Manufacturing

2 years ago 10 Likes 251
News

How to Overcome the Challenges in Biologics Development

2 years ago 13 Likes 223
News

Gene Therapies: Overcoming the Biggest Hurdles in Manufacturing

2 years ago 12 Likes 249
[cm_ad_changer group_id="3"]

Recent Posts

  • Blue Lake Biotechnology RSV vaccine gets FDA fast track
  • Companies partner on early lung cancer detection blood test
  • Animal-free milk company Imagindairy reaches $28M in funding
  • Labiotech goes global
  • Duke Street Bio enters stage with next-generation cancer therapies
  • Vaccines mobilized to control monkeypox outbreak
  • The organoid era: Bringing patient-relevant preclinical models to the lab
  • The coming of age of European synthetic biology
  • Zealand Pharma’s drug for rare metabolic disease smashes phase III
  • Evotec, Sernova in partnership to develop beta cell diabetes therapy
[cm_ad_changer group_id="4"]
[cm_ad_changer group_id="5"]
© 2020 biotechTODAY - Designed by Legendary Group